Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower ...

Skye Bioscience has published 52-week data on its investigational obesity drug combination, linking the cocktail to 22.3% ...

NEW YORK — A new pill form of the weight-loss drug Wegovy is now available to people in the United States, giving adults a daily tablet option instead of a weekly injection, health officials and the ...

Britain’s regulator approves a dose of up to 7.2 mg of semaglutide per week, up from 2.4 mg.

The cost of weight loss drug Wegovy will soon be massively subsidised for Australians with severe obesity who have had a stroke or heart attack.

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

The oral weight-loss drug introduced by Novo Nordisk this year in the U.S. is quickly being adopted.

Add Yahoo as a preferred source to see more of our stories on Google. Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight.

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...